Göm menyn

Publications for Mattias Aronsson

Publications mentioned in social media 107 times*

Journal Articles

Mattias Aronsson, Per Carlsson, Lars-Åke Levin, Jakob Hager and R. Hultcrantz
  Cost-effectiveness of high-sensitivity faecal immunochemical test and colonoscopy screening for colorectal cancer
  British Journal of Surgery, 2017, 104(8), 1078-1086.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Mattias Aronsson, Emma Svennberg, Mårten Rosenqvist, Johan Engdahl, Faris Al-Khalili, Leif Friberg, Viveka Frykman and Lars-Åke Levin
  Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis.
  Europace, 2017, 19(10), 1650-1656.

Josefine Persson, Mattias Aronsson, Lukas Holmegaard, Petra Redfors, Kaj Stenlof, Katarina Jood, Christina Jern, Christian Blomstrand, Gunilla Forsberg-Warleby and Lars-Åke Levin
  Long-term QALY-weights among spouses of dependent and independent midlife stroke survivors
  Quality of Life Research, 2017, 26(11), 3059-3068.
   Fulltext  PDF  

Mattias Aronsson, Josefine Persson, Christian Blomstrand, Per Wester and Lars-Åke Levin
  Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke
  Neurology, 2016, 86(11), 1053-1059.
   Fulltext  PDF  
 Web of Science® Times Cited: 30

Mattias Aronsson, Emma Svennberg, Marten Rosenqvist, Johan Engdahl, Faris Al-Khalili, Leif Friberg, Viveka Frykman-Kull and Lars-Åke Levin
  Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording
  Europace, 2015, 17(7), 1023-1029.
 Web of Science® Times Cited: 34

Mattias Aronsson, Magnus Husberg, Almina Kalkan, Nathalie Eckard and Jenny Alwin
  Differences between hypothetical and experience-based value sets for EQ-5D used in Sweden: Implications for decision makers
  Scandinavian Journal of Public Health, 2015, 43(8), 848-854.
   Fulltext  PDF  
 Web of Science® Times Cited: 6

Håkan Walfridsson, Ulla Walfridsson, J. Cosedis Nielsen, A. Johannessen, P. Raatikainen, Magnus Janzon, Lars-Åke Levin, Mattias Aronsson, G. Hindricks, O. Kongstad, S. Pehrson, A. Englund, J. Hartikainen, L. S. Mortensen and P. S. Hansen
  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial
  Europace, 2015, 17(2), 215-221.
 Web of Science® Times Cited: 23

Mattias Aronsson, Håkan Walfridsson, Magnus Janzon, Ulla Walfridsson, Jens Cosedis Nielsen, Peter Steen Hansen, Arne Johannessen, Pekka Raatikainen, Gerhard Hindricks, Ole Kongstad, Steen Pehrson, Anders Englund, Juha Hartikainen, Leif Spange Mortensen and Lars-Åke Levin
  The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
  Europace, 2015, 17(1), 48-55.
   Fulltext  PDF  
 Web of Science® Times Cited: 12

Ph.D. Theses

Mattias Aronsson
  Health Economic Evaluations of Screening Programs - Applications and Method Improvements

  Fulltext PDF


Mattias Aronsson, Per Carlsson and Lars-Åke Levin
  Hälsoekonomisk förstudie av digital patologi: Var finns de potentiella vinsterna?
  CMT Rapport, 2015:1, 2015.

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2010-08-30